These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 737897)
1. Stimulated autoantibody response and increased longevity in NZB/NZW mice treated with cyclophosphamide and tilorone. Walker SE; Anver MR Clin Exp Immunol; 1978 Sep; 33(3):453-62. PubMed ID: 737897 [TBL] [Abstract][Full Text] [Related]
2. Acceleration of glomerulonephritis in NZB x NZW mice by early immunization with DNA and injection of bacterial lipopolysaccharide. Experimental approach to the treatment of lupus nephritis by use of the accelerated model of NZB x NZW mouse disease. Fournie GJ; Minh MG; Mignon-Conte MA; Hass S; Lambert PH; Conte JJ J Clin Lab Immunol; 1980 Sep; 4(2):103-6. PubMed ID: 7441709 [TBL] [Abstract][Full Text] [Related]
3. Animal models utilized in the research of autoimmune disease control: experimental therapy of glomerulonephritis in NZB/W F1 mice. Okudaira H; Terada E; Okudaira K Prog Clin Biol Res; 1987; 229():157-74. PubMed ID: 3601985 [TBL] [Abstract][Full Text] [Related]
4. Early appearance of abnormally migrating serum IgM in control and cyclophosphamide-treated NZB/NZW mice. Walker SE J Rheumatol; 1982; 9(2):183-8. PubMed ID: 6980279 [TBL] [Abstract][Full Text] [Related]
5. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice. Hughes GC; Martin D; Zhang K; Hudkins KL; Alpers CE; Clark EA; Elkon KB Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860 [TBL] [Abstract][Full Text] [Related]
6. Isoprinosine delays the early appearance of autoimmunity in NZB/NZW F1 mice treated with interferon. Sergiescu D; Cerutti I; Kahan A; Piatier D; Efthymiou E Clin Exp Immunol; 1981 Jan; 43(1):36-45. PubMed ID: 6166417 [TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204 [TBL] [Abstract][Full Text] [Related]
8. Backcross analysis of genes linked to autoantibody production in New Zealand White mice. Vyse TJ; Morel L; Tanner FJ; Wakeland EK; Kotzin BL J Immunol; 1996 Sep; 157(6):2719-27. PubMed ID: 8805679 [TBL] [Abstract][Full Text] [Related]
9. The mechanism of action of cyclophosphamide on the nephritis of (NZB x NZW)F1 hybrid mice. Hurd ER; Ziff M Clin Exp Immunol; 1977 Jul; 29(1):132-9. PubMed ID: 302170 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse. Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055 [TBL] [Abstract][Full Text] [Related]
11. Prolonged lifespan and high incidence of neoplasms in NZB/NZW mice treated with hydrocortisone sodium succinate. Walker SE; Anver MR; Schechter SL; Bole GG Kidney Int; 1978 Aug; 14(2):151-7. PubMed ID: 691974 [TBL] [Abstract][Full Text] [Related]
12. Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB X NZW)F1 hybrid and the correlation to renal disease. Maruyama N; Furukawa F; Nakai Y; Sasaki Y; Ohta K; Ozaki S; Hirose S; Shirai T J Immunol; 1983 Feb; 130(2):740-6. PubMed ID: 6217253 [TBL] [Abstract][Full Text] [Related]
13. Accelerated appearance of neoplasms in female NZB/NZW mice treated with high-dose cyclophosphamide. Walker SE; Anver MR Arthritis Rheum; 1979 Dec; 22(12):1338-43. PubMed ID: 391238 [TBL] [Abstract][Full Text] [Related]
14. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization. Rudofsky UH; Evans BD; Balaban SL; Mottironi VD; Gabrielsen AE Lab Invest; 1993 Apr; 68(4):419-26. PubMed ID: 8479150 [TBL] [Abstract][Full Text] [Related]
15. High incidence of neoplasms in female NZB/NZW mice treated with pulse doses of cyclophosphamide. Walker SE; Anver MR Vet Immunol Immunopathol; 1983 Nov; 5(1):97-104. PubMed ID: 6606891 [TBL] [Abstract][Full Text] [Related]
17. Prolongation of life in female NZB/NZW (F1) hybrid mice by cyclosporin A. Jones MG; Harris G Clin Exp Immunol; 1985 Jan; 59(1):1-9. PubMed ID: 3882281 [TBL] [Abstract][Full Text] [Related]
18. In vivo and in vitro production of anti-histone antibodies in NZB/NZW mice. Gioud M; Kotzin BL; Rubin RL; Joslin FG; Tan EM J Immunol; 1983 Jul; 131(1):269-74. PubMed ID: 6863918 [TBL] [Abstract][Full Text] [Related]
19. Treatment of NZB/NZW mice with total lymphoid irradiation: long-lasting suppression of disease without generalized immune suppression. Kotzin BL; Arndt R; Okada S; Ward R; Thach AB; Strober S J Immunol; 1986 May; 136(9):3259-65. PubMed ID: 2937842 [TBL] [Abstract][Full Text] [Related]